Clinical Trials Directory

Trials / Conditions / HER2 Negative

HER2 Negative

7 registered clinical trials studyying HER2 Negative — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingHS-10502 Combination Treatment in Patients With Advanced Solid Tumors
NCT06769425
Jiangsu Hansoh Pharmaceutical Co., Ltd.Phase 1
RecruitingPhase II Trial of Iparomlimab/Tuvonralimab (QL1706) + XELOX in HER2-Negative, Low PD-L1 G/GEJ Adenocarcinoma
NCT06932068
Qilu Hospital of Shandong UniversityPhase 2
CompletedNIS Study Determining Prevalence of HER2-low in Metastatic Breast Cancer Patients
NCT06131424
AstraZeneca—
UnknownTirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric Cancer
NCT06284746
Lin ChenPhase 2
UnknownER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study)
NCT04669587
EnhancedBio USA Inc.Phase 1 / Phase 2
Active Not RecruitingA Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Can
NCT04757363
Memorial Sloan Kettering Cancer CenterPhase 2
CompletedCarboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer
NCT03206203
Vanderbilt-Ingram Cancer CenterPhase 2